^
Association details:
| Biomarker: | IDH2 mutation |
|---|---|
| Cancer: | Anaplastic Astrocytoma |
| Regimen: | (lomustine + Matulane (procarbazine hydrochloride) + vincristine) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Radiotherapy-PCV versus radiotherapy-temozolomide for IDH-mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort
Published date:
02/01/2021
Excerpt:
The 4-year PFS in the RT + PCV arm was 70.8% vs 53.5% in the RT + TMZ arm...RT + PCV significantly improved PFS compared to RT + TMZ for IDH-mutant AA.
DOI:
10.1002/onco.13701
